Background illustration for clinical trials search

Paid Clinical Trials Clearwater

Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

for
Acne
Location: Brandon FL, Jacksonville FL, New Orleans LA, Encino CA
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT07013747

Phase 1, Phase 2, Recruiting

Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study

for
Drug; Withdrawal Symptoms, Neonatal, Withdrawal,
Location: St Petersburg FL
Sponsor: Gauda, Estelle B., M.D.

Sex: All

Age: 0

Code: NCT02249026

Phase 1, Phase 2, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for
Solid Tumors Harboring MET Amplification
Location: St. Petersburg FL, Durham NC, Nashville TN, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase 2, Recruiting

PEN-866 in Patients With Advanced Solid Malignancies

for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Saint Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Tarveda Therapeutics

Sex: All

Age: 18+

Code: NCT03221400

Phase 1, Phase 2, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Tampa FL, Clermont FL, Kissimmee FL, Orlando FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Tampa FL, Kissimmee FL, Miami FL, Atlanta GA,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07185009

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Tampa FL, Clermont FL, Kissimmee FL, Orlando FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase 3, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Tampa FL, Kissimmee FL, Orlando FL, Miami FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184944

Phase 3, Recruiting
New

A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)

for
Chronic Spontaneous Urticaria (CSU),
Location: Tampa FL, Altamonte Springs FL, Atlanta GA,
Sponsor: Calixis Inc.

Sex: All

Age: 18 - 70+

Code: NCT07766499

Phase 2, Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Tampa FL, Winter Park FL, Gainesville FL,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase 3, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Tampa FL, St. Petersburg FL, Boca Raton FL, Macon GA,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase 3, Recruiting

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

for
Geographic Atrophy
Location: St. Petersburg FL, Gainesville FL, Stuart FL, Ladson SC,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07215234

Phase 1, Phase 2, Recruiting

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

for
Atopic Dermatitis
Location: Saint Petersburg FL, Orange City FL, Saint Augustine FL,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05694884

Phase 2, Recruiting

Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study

for
Tinea Unguium, Onychomycosis
Location: Saint Petersburg FL
Sponsor: William N Handelman

Sex: All

Age: 21 - 70+

Code: NCT04341402

Phase 2, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Sarasota FL, Lexington KY, Edgewood KY, Houston TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06682988

Phase 2, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: St. Petersburg FL, Tampa FL, Brandon FL, Sarasota FL,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase 3, Recruiting

Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)

for
Obstructive Sleep Apnea
Location: St. Petersburg FL, Dallas TX
Sponsor: ApniCure, Inc.

Sex: All

Age: 18+

Code: NCT01683721

Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Tampa FL, Jacksonville FL, Miami FL, Durham NC,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase 2, Recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: St. Petersburg FL, Orange City FL, Gainesville FL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase 3, Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

for
Pruritus
Location: Belleair FL, Miami FL, Savannah GA, Macon GA,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT05263206

Phase 3, Recruiting